Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation

Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page

  1. Check
    today
    Change Detected
    Summary
    The NIVOLEP clinical-trial record is displayed with its study details, including nivolumab treatment and electroporation for hepatocellular carcinoma. It also indicates that enrollment was terminated after recruitment was affected by the COVID-19 pandemic.
    Difference
    52%
    Check dated 2026-11-07T12:19:46.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T13:06:08.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:26:03.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:10:05.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T16:14:18.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The study record page shows a 403 Forbidden message and a Home link in place of the trial details.
    Difference
    0.5%
    Check dated 2026-10-03T16:03:59.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.